Funding for this research was provided by:
Health Sciences Centre Foundation
Mitacs
Article History
Received: 23 August 2021
Accepted: 10 January 2022
First Online: 27 January 2022
Declarations
:
: This study has been approved by the University of Manitoba Health Research Ethics Board.
: Informed consent was obtained from all individual participants in the study.
: Dr. Charles Bernstein has consulted to Abbvie Canada, Amgen Canada, Janssen Canada, Pfizer Canada, Roche Canada, Bristol Myers Squibb Canada, Sandoz Canada, Takeda Canada and Mylan Pharamceuticals, and has received unrestricted educational grants from Abbvie Canada, Janssen Canada, Pfizer Canada and Takeda Canada. He has been on speaker’s bureaus of Abbvie Canada Janssen Canada, Takeda Canada and Medtronic Canada. All other authors declare no conflict of interest.